NHC
National HealthCare Corporation
AMEX: NHC · HEALTHCARE · MEDICAL CARE FACILITIES
$189.75
+2.19% today
Updated 2026-06-05
Market cap
$2.84B
P/E ratio
23.09
P/S ratio
1.88x
EPS (TTM)
$7.87
Dividend yield
1.39%
52W range
$92 – $205
Volume
0.1M
National HealthCare Corporation (NHC) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed NHC price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$189.75
Today
Analyst consensus
$6.15
-96.76% · 12M
2030 Base
$225.02
+18.59% future
NPV today
$157.14
@ 8% WACC
4 analysts:
2 Buy2 Hold0 Sell
Management guidance
Management has not provided explicit revenue targets through 2030. However, CEO Stephen Flatt has signaled aggressive growth through the $560M acquisition of 35 NHI facilities (32 SNFs + 3 independent living communities) closing July 1, 2026, which represents ~37% revenue accretion to the $1.52B 2025 base. The company has raised dividends for 12 consecutive years, indicating confidence in sustained cash generation and growth.
Sources: Management guidance, analyst consensus, sector analysishigh confidence
NHC · National HealthCare Corporation · Revenue & price projection · 2023–2030E
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
$225.02
NPV today: $157.14
Base case (2030)
$225.02
NPV today: $157.14
Bull case (2030)
$431.29
NPV today: $301.18
WallStSmart.com
NHC financial forecast · Research-backed projections
| Metric | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) ★ |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.1B | $2.5B | $2.7B | $3.0B | $3.2B |
| Revenue growth | 16.4% | 37.3% | 17.6% | 11.6% | 9.0% | 8.3% |
| Net margin | — | 8.9% | 9.1% | 9.1% | 9.1% | 9.2% |
| EPS | $7.67 | $11.85 | $14.21 | $15.94 | $17.39 | $18.88 |
| Diluted shares | — | 16M | 16M | 16M | 16M | 16M |
| Net debt | — | $-45.47M | $-98.96M | $-158.67M | $-223.77M | $-294.28M |
| P/S multiple | — | 1.0x | 1.0x | 1.0x | 1.0x | 1.0x |
| Implied price (base) | — | $136.45 | $163.25 | $185.15 | $204.87 | $225.02 |
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
| 2030E driver | Bear | Base | Bull |
|---|---|---|---|
| Revenue | $3.2B | $3.2B | $3.2B |
| P/S multiple | 1.0x | 1.0x | 2.0x |
| Diluted shares | 16M | 16M | 16M |
| Net debt | $-294.28M | $-294.28M | $-294.28M |
| Implied P/E † | 12x | 12x | 23x |
| 2030 Price | $225.02 | $225.02 | $431.29 |
| NPV @ 8% | $157.14 | $157.14 | $301.18 |
† Implied P/E: Multiples remain elevated across all three scenarios because NHC is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $225.02 base case
NHC catalysts and risks
Growth catalysts
+ $560M NHI acquisition of 35 facilities closes July 2026 (~37% revenue accretion); 5 SNFs already closed May 2026 for $50.5M
+ Demographic tailwind: aging Baby Boomer population driving demand for senior care facilities (SNFs, assisted living, homecare) through 2030
+ 12-year dividend growth streak + 4.7% raise (May 2026) signals management confidence in sustained operating leverage and M&A capacity
+ Operating margin expansion potential as newly acquired NHI facilities (currently 100% operated by NHC) transition to full ownership with operational synergies
Key risks
- Healthcare sector regulatory risk: Medicare/Medicaid reimbursement rate pressure, staffing mandates, compliance costs could compress margins below current 8.1% level
- Integration execution risk: $560M acquisition must achieve synergy targets and maintain occupancy rates during transition (typically 6-12 month risk window)
- Wage inflation in SNF/assisted living sector: labor represents 60-70% of operating costs; continued wage pressure could offset revenue growth
- Macroeconomic slowdown reducing private-pay occupancy in assisted living and independent living communities
Methodology · National HealthCare Corporation 2030 stock forecast model
National HealthCare Corporation 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 4 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
| 1. Share dilution | Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (1% cumulative for NHC by 2030) |
| 2. Net debt | EV minus net debt yields equity value; debt projected from capex cycle trajectory ($-294.28M by 2030) |
| 3. Time value | NPV calculated using 8% WACC (CAPM: beta 0.651) |
| 4. Multiple framework | P/S compresses with scale: bear 1.0x / base 1.0x / bull 2.0x |
| 5. Scenario design | Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently |
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: May 21, 2026.
NHC price target FAQ
What is the NHC price target for 2030?
WallStSmart's National HealthCare Corporation 2030 base case is $225.02 per share, with a bull case of $431.29 and bear case of $225.02. The NPV of the base case discounted to today at 8% WACC is $157.14.
How is the National HealthCare Corporation 2030 stock forecast calculated?
The NHC 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
Why does the NHC price target account for dilution?
National HealthCare Corporation is projected to grow diluted share count from 16M to 16M by 2030 (a 1% increase) through stock-based compensation and capital raises. Ignoring this would inflate the price target by approximately 1%.
What is the analyst consensus on NHC stock?
4 analysts cover NHC with an average 12-month price target of $—. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.